ZOMIG nasal spray nasal 5 mg monodos 6 pce
7680560030049
CH-56003
N02CC03
02.05.1.
Reimbursement limitations:
ZOMIG NASAL
Utilisation uniquement en cas de crise de migraine de moyenne ou forte intensité.
1 / 3
google
Details
- Product number
- 5600301
- CPT
- -
- Packaging group
- 6
- Unit
- Dose(n)
- Composition
- zolmitriptanum 5 mg, acidum citricum, dinatrii phosphas, aqua purificata ad solutionem pro dosi 0.1 ml.
Articles (1)
Zomig nasal 5 mg, Nasenspray
Nasenspray
6
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 77.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2005
Authorization holder
Grünenthal Pharma AG
None Glarus Süd
Authorization information
- Swissmedic authorization number
- 56003
- Drug name
- Zomig nasal, Nasenspray
- Galenic form
- NASS
- ATC Code
- N02CC03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 03/11/2004
- Authorization expiration date
- 31/12/9999
- IT number
- 02.05.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ZOMIG nasal spray nasal 5 mg monodos 6 pce
- Description (DE)
- ZOMIG nasal Nasenspray 5 mg Monodos 6 Stk
- Market launch
- 03/11/2004
- Narcotic (BTM)
- No